Post-transplant lymphoproliferative disorder (PTLD) poses significant risks following organ transplantation, characterized by potential aggressiveness. This report aims to discuss a case of PTLD presenting as B-cell large-cell lymphoma (DLBCL) post kidney and pancreas transplantation. A 44-year-old female with type 1 diabetes underwent simultaneous cadaver kidney and pancreas transplantation. She presented with fever, night sweats, and weakness, revealing multiple lesions on CT, including in transplanted and native kidneys and pancreas. A biopsy of the transplant kidney confirmed PTLD, DLBCL subtype, with complex immunohistochemical findings. Chemotherapy (R-CHOP) was initiated but complicated by bowel perforation necessitating surgery and antibiotics, transplant renal vein thrombosis, pyelonephritis, and neutropenia. Despite the complications, the normal function of the transplanted kidney was maintained, which made it possible to implement the standard chemotherapy protocol. This case underscores the diagnostic challenges and therapeutic complexities of PTLD, specifically DLBCL, in transplant recipients. The co-infection of COVID-19 and aspergillosis in a multiple immunocompromised patient indicated a possible rapid course of the disease with global respiratory insufficiency and a fatal outcome despite all applied therapeutic modalities.
Invasive fungal infections can present with rapidly progressive tissue injury before microbiological confirmation is available. Emergency imaging must identify the affected organ, detect complications and guide further diagnostic assessment. This narrative review synthesizes selected imaging studies and consensus guidance on computed tomography, magnetic resonance imaging and ultrasonography in adult emergency and acute-care settings. Findings are interpreted according to fungal biology, host immune status and disease timing. Pulmonary manifestations include angioinvasive and airway-predominant patterns; sinonasal assessment emphasizes extrasinus extension, tissue viability and orbital or intracranial complications. Central nervous system imaging addresses abscesses, infarction and haemorrhage, while abdominal and urinary assessment identifies visceral lesions, bowel compromise and obstruction. Critical appraisal of selected studies highlights limitations related to patient selection, small samples, reference standards and transferability of diagnostic estimates. The review connects these findings to examination selection, vascular assessment, urgent communication and sampling targets through a proposed clinical workflow. Imaging supports suspicion and defines disease extent but cannot independently establish fungal aetiology. Prospective studies are needed to determine whether integrated imaging pathways improve diagnostic timing and patient outcomes.